Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 333

1.

The Importance of Considering Sex and Gender in Cardiovascular Research.

Scovelle AJ, Milner A, Beauchamp A, Byrnes J, Norton R, Woodward M, O'Neil A.

Heart Lung Circ. 2019 Sep 7. pii: S1443-9506(19)31415-5. doi: 10.1016/j.hlc.2019.08.011. [Epub ahead of print] No abstract available.

PMID:
31526681
2.

Developing a cerebral palsy-specific preference-based measure for a six-dimensional classification system (CP-6D): protocol for a valuation study.

Bahrampour M, Norman R, Byrnes J, Downes M, Scuffham PA.

BMJ Open. 2019 Sep 12;9(9):e029325. doi: 10.1136/bmjopen-2019-029325.

3.

Outcomes of transcatheter aortic valve implantation for intermediate-risk patients in Australia: the SOLACE-AU trial.

Lee P, Byrnes J, Mervin M, Scuffham P.

J Med Econ. 2019 Sep 11:1-9. doi: 10.1080/13696998.2019.1663356. [Epub ahead of print]

PMID:
31491351
4.

A Prospective Analysis of Genetic Variants Associated with Human Lifespan.

Wright KM, Rand KA, Kermany A, Noto K, Curtis D, Garrigan D, Slinkov D, Dorfman I, Granka JM, Byrnes J, Myres N, Ball CA, Ruby JG.

G3 (Bethesda). 2019 Sep 4;9(9):2863-2878. doi: 10.1534/g3.119.400448.

5.

Post-translational Protein Acetylation: An Elegant Mechanism for Bacteria to Dynamically Regulate Metabolic Functions.

Christensen DG, Xie X, Basisty N, Byrnes J, McSweeney S, Schilling B, Wolfe AJ.

Front Microbiol. 2019 Jul 12;10:1604. doi: 10.3389/fmicb.2019.01604. eCollection 2019. Review.

6.

Identifying compliant participants through data matching improved estimation of intervention efficacy: randomized trials with opt-in/opt-out strategies.

Ng SK, Byrnes J, Scuffham P.

J Clin Epidemiol. 2019 Jul 24;115:125-132. doi: 10.1016/j.jclinepi.2019.07.013. [Epub ahead of print]

PMID:
31351121
7.

Structure-function analysis of β-arrestin Kurtz reveals a critical role of receptor interactions in downregulation of GPCR signaling in vivo.

Chai F, Xu W, Musoke T, Tarabelsi G, Assaad S, Freedman J, Peterson R, Piotrowska K, Byrnes J, Rogers S, Veraksa A.

Dev Biol. 2019 Jul 17. pii: S0012-1606(19)30314-8. doi: 10.1016/j.ydbio.2019.07.013. [Epub ahead of print]

PMID:
31325455
8.

A systematic review of the validity and reliability of patient-reported experience measures.

Bull C, Byrnes J, Hettiarachchi R, Downes M.

Health Serv Res. 2019 Oct;54(5):1023-1035. doi: 10.1111/1475-6773.13187. Epub 2019 Jun 19.

PMID:
31218671
9.

Within trial cost-utility analysis of disease management program for patients hospitalized with atrial fibrillation: results from the SAFETY trial.

Byrnes J, Ball J, Gao L, Kai Chan Y, Kularatna S, Stewart S, Scuffham PA.

J Med Econ. 2019 Sep;22(9):945-952. doi: 10.1080/13696998.2019.1631831. Epub 2019 Jul 4.

PMID:
31190590
10.

Pediatric Quality of Life Instruments in Oral Health Research: A Systematic Review.

Hettiarachchi RM, Kularatna S, Byrnes J, Scuffham PA.

Value Health. 2019 Jan;22(1):129-135. doi: 10.1016/j.jval.2018.06.019. Epub 2018 Sep 8.

PMID:
30661626
11.

Economic Analysis of a Three-Arm RCT Exploring the Delivery of Intensive, Prophylactic Swallowing Therapy to Patients with Head and Neck Cancer During (Chemo)Radiotherapy.

Wall LR, Kularatna S, Ward EC, Cartmill B, Hill AJ, Isenring E, Byrnes J, Porceddu SV.

Dysphagia. 2019 Oct;34(5):627-639. doi: 10.1007/s00455-018-9960-1. Epub 2018 Dec 4.

PMID:
30515560
12.

We Respect Their Autonomy and Dignity, But How Do We Value Patient-Reported Experiences?

Bull C, Byrnes J, Mulhern B.

MDM Policy Pract. 2018 Nov 7;3(2):2381468318807458. doi: 10.1177/2381468318807458. eCollection 2018 Jul-Dec. No abstract available.

13.

Coagulation factor XIIIa cross-links amyloid β into dimers and oligomers and to blood proteins.

Hur WS, Mazinani N, Lu XJD, Yefet LS, Byrnes JR, Ho L, Yeon JH, Filipenko S, Wolberg AS, Jefferies WA, Kastrup CJ.

J Biol Chem. 2019 Jan 11;294(2):390-396. doi: 10.1074/jbc.RA118.005352. Epub 2018 Nov 8.

PMID:
30409906
14.

Estimates of the Heritability of Human Longevity Are Substantially Inflated due to Assortative Mating.

Ruby JG, Wright KM, Rand KA, Kermany A, Noto K, Curtis D, Varner N, Garrigan D, Slinkov D, Dorfman I, Granka JM, Byrnes J, Myres N, Ball C.

Genetics. 2018 Nov;210(3):1109-1124. doi: 10.1534/genetics.118.301613.

PMID:
30401766
15.

MRI review of female pelvic fistulizing disease.

Hyde BJ, Byrnes JN, Occhino JA, Sheedy SP, VanBuren WM.

J Magn Reson Imaging. 2018 Nov;48(5):1172-1184. doi: 10.1002/jmri.26248.

PMID:
30347131
16.

Comprehensive Management Considerations of Select Noncardiac Organ Systems in the Cardiac Intensive Care Unit.

Huff C, Mastropietro CW, Riley C, Byrnes J, Kwiatkowski DM, Ellis M, Schuette J, Justice L.

World J Pediatr Congenit Heart Surg. 2018 Nov;9(6):685-695. doi: 10.1177/2150135118779072. Review.

PMID:
30322370
17.

The Impact of Population-Based Disease Management Services on Health Care Utilisation and Costs: Results of the CAPICHe Trial.

Scuffham PA, Byrnes JM, Pollicino C, Cross D, Goldstein S, Ng SK.

J Gen Intern Med. 2019 Jan;34(1):41-48. doi: 10.1007/s11606-018-4682-5. Epub 2018 Sep 27.

PMID:
30264259
18.

Cost of vascular access devices in public hospitals in Queensland.

Tuffaha HW, Marsh N, Byrnes J, Gavin N, Webster J, Cooke M, Rickard CM.

Aust Health Rev. 2018 Sep 4. doi: 10.1071/AH18102. [Epub ahead of print]

PMID:
30176985
19.

International HTA Experience with Targeted Therapy Approvals for Lung Cancer.

Maraiki F, Byrnes J, Tuffaha H, Hinder M.

Pharmacoecon Open. 2019 Mar;3(1):103-117. doi: 10.1007/s41669-018-0088-x.

20.

Personalised telehealth intervention for chronic disease management: A pilot randomised controlled trial.

Bohingamu Mudiyanselage S, Stevens J, Watts JJ, Toscano J, Kotowicz MA, Steinfort CL, Bell J, Byrnes J, Bruce S, Carter S, Hunter C, Barrand C, Hayles R.

J Telemed Telecare. 2019 Jul;25(6):343-352. doi: 10.1177/1357633X18775850. Epub 2018 May 24.

PMID:
29793387
21.

Integrated versus nOn-integrated Peripheral inTravenous catheter. Which Is the most effective systeM for peripheral intravenoUs catheter Management? (The OPTIMUM study): a randomised controlled trial protocol.

Castillo MI, Larsen E, Cooke M, Marsh NM, Wallis MC, Finucane J, Brown P, Mihala G, Carr PJ, Byrnes J, Walker R, Cable P, Zhang L, Sear C, Jackson G, Rowsome A, Ryan A, Humphries JC, Sivyer S, Flanigan K, Rickard CM.

BMJ Open. 2018 May 14;8(5):e019916. doi: 10.1136/bmjopen-2017-019916.

22.

Australian cardiac rehabilitation exercise parameter characteristics and perceptions of high-intensity interval training: a cross-sectional survey.

Hannan AL, Hing W, Climstein M, Coombes JS, Furness J, Jayasinghe R, Byrnes J.

Open Access J Sports Med. 2018 Apr 30;9:79-89. doi: 10.2147/OAJSM.S160306. eCollection 2018.

23.

Biallelic Mutations in MRPS34 Lead to Instability of the Small Mitoribosomal Subunit and Leigh Syndrome.

Lake NJ, Webb BD, Stroud DA, Richman TR, Ruzzenente B, Compton AG, Mountford HS, Pulman J, Zangarelli C, Rio M, Boddaert N, Assouline Z, Sherpa MD, Schadt EE, Houten SM, Byrnes J, McCormick EM, Zolkipli-Cunningham Z, Haude K, Zhang Z, Retterer K, Bai R, Calvo SE, Mootha VK, Christodoulou J, Rötig A, Filipovska A, Cristian I, Falk MJ, Metodiev MD, Thorburn DR.

Am J Hum Genet. 2018 Apr 5;102(4):713. doi: 10.1016/j.ajhg.2018.03.015. No abstract available.

24.

Anomalous K-Pg-aged seafloor attributed to impact-induced mid-ocean ridge magmatism.

Byrnes JS, Karlstrom L.

Sci Adv. 2018 Feb 7;4(2):eaao2994. doi: 10.1126/sciadv.aao2994. eCollection 2018 Feb.

25.

High-intensity interval training versus moderate-intensity continuous training within cardiac rehabilitation: a systematic review and meta-analysis.

Hannan AL, Hing W, Simas V, Climstein M, Coombes JS, Jayasinghe R, Byrnes J, Furness J.

Open Access J Sports Med. 2018 Jan 26;9:1-17. doi: 10.2147/OAJSM.S150596. eCollection 2018. Review.

26.

Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice.

Kattula S, Byrnes JR, Martin SM, Holle LA, Cooley BC, Flick MJ, Wolberg AS.

Blood Adv. 2018 Jan 3;2(1):25-35. doi: 10.1182/bloodadvances.2017011890. eCollection 2018 Jan 9.

27.

Thermoelectric Performance of Na-Doped GeSe.

Shaabani L, Aminorroaya-Yamini S, Byrnes J, Akbar Nezhad A, Blake GR.

ACS Omega. 2017 Dec 31;2(12):9192-9198. doi: 10.1021/acsomega.7b01364. Epub 2017 Dec 26.

28.

Impact of Cytomegalovirus Viral Load on Probability of Spontaneous Clearance and Response to Preemptive Therapy in Allogeneic Stem Cell Transplantation Recipients.

Camargo JF, Kimble E, Rosa R, Shimose LA, Bueno MX, Jeyakumar N, Morris MI, Abbo LM, Simkins J, Alencar MC, Benjamin C, Wieder E, Jimenez A, Beitinjaneh A, Goodman M, Byrnes JJ, Lekakis LJ, Pereira D, Komanduri KV.

Biol Blood Marrow Transplant. 2018 Apr;24(4):806-814. doi: 10.1016/j.bbmt.2017.11.038. Epub 2017 Dec 5.

29.

Economic evaluation of a nurse-led home and clinic-based secondary prevention programme to prevent progressive cardiac dysfunction in high-risk individuals: The Nurse-led Intervention for Less Chronic Heart Failure (NIL-CHF) randomized controlled study.

Maru S, Byrnes J, Carrington MJ, Chan YK, Stewart S, Scuffham PA; NIL-CHF Trial Investigators.

Eur J Cardiovasc Nurs. 2018 Jun;17(5):439-445. doi: 10.1177/1474515117743979. Epub 2017 Nov 23.

PMID:
29166769
30.

Coaching Patients Saves Lives and Money.

Byrnes J, Elliott T, Vale MJ, Jelinek MV, Scuffham P.

Am J Med. 2018 Apr;131(4):415-421.e1. doi: 10.1016/j.amjmed.2017.10.019. Epub 2017 Dec 11.

PMID:
29106978
31.

A New Benchmark for Pediatric Extracorporeal Membrane Oxygenation Research.

Byrnes JW.

Pediatr Crit Care Med. 2017 Nov;18(11):1072-1073. doi: 10.1097/PCC.0000000000001312. No abstract available.

PMID:
29099449
32.

Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Tompkins BA, DiFede DL, Khan A, Landin AM, Schulman IH, Pujol MV, Heldman AW, Miki R, Goldschmidt-Clermont PJ, Goldstein BJ, Mushtaq M, Levis-Dusseau S, Byrnes JJ, Lowery M, Natsumeda M, Delgado C, Saltzman R, Vidro-Casiano M, Da Fonseca M, Golpanian S, Premer C, Medina A, Valasaki K, Florea V, Anderson E, El-Khorazaty J, Mendizabal A, Green G, Oliva AA, Hare JM.

J Gerontol A Biol Sci Med Sci. 2017 Oct 12;72(11):1513-1522. doi: 10.1093/gerona/glx137.

33.

Cost analysis of a speech pathology synchronous telepractice service for patients with head and neck cancer.

Burns CL, Kularatna S, Ward EC, Hill AJ, Byrnes J, Kenny LM.

Head Neck. 2017 Dec;39(12):2470-2480. doi: 10.1002/hed.24916. Epub 2017 Sep 30.

PMID:
28963804
34.

The cost-effectiveness of oral health interventions: A systematic review of cost-utility analyses.

Hettiarachchi RM, Kularatna S, Downes MJ, Byrnes J, Kroon J, Lalloo R, Johnson NW, Scuffham PA.

Community Dent Oral Epidemiol. 2018 Apr;46(2):118-124. doi: 10.1111/cdoe.12336. Epub 2017 Sep 19.

PMID:
28925508
35.

Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study).

Florea V, Rieger AC, DiFede DL, El-Khorazaty J, Natsumeda M, Banerjee MN, Tompkins BA, Khan A, Schulman IH, Landin AM, Mushtaq M, Golpanian S, Lowery MH, Byrnes JJ, Hendel RC, Cohen MG, Valasaki K, Pujol MV, Ghersin E, Miki R, Delgado C, Abuzeid F, Vidro-Casiano M, Saltzman RG, DaFonseca D, Caceres LV, Ramdas KN, Mendizabal A, Heldman AW, Mitrani RD, Hare JM.

Circ Res. 2017 Nov 10;121(11):1279-1290. doi: 10.1161/CIRCRESAHA.117.311827. Epub 2017 Sep 18.

PMID:
28923793
36.

Efficacy and safety of recombinant tissue plasminogen activator for venous thrombosis after paediatric heart surgery.

Justice LB, Nelson DP, Palumbo J, Sawyer J, Patel MN, Byrnes JW.

Cardiol Young. 2018 Feb;28(2):214-221. doi: 10.1017/S104795111700172X. Epub 2017 Sep 11.

PMID:
28889818
37.

Lineage overwhelms environmental conditions in determining rhizosphere bacterial community structure in a cosmopolitan invasive plant.

Bowen JL, Kearns PJ, Byrnes JEK, Wigginton S, Allen WJ, Greenwood M, Tran K, Yu J, Cronin JT, Meyerson LA.

Nat Commun. 2017 Sep 5;8(1):433. doi: 10.1038/s41467-017-00626-0.

38.

Red blood cells in thrombosis.

Byrnes JR, Wolberg AS.

Blood. 2017 Oct 19;130(16):1795-1799. doi: 10.1182/blood-2017-03-745349. Epub 2017 Aug 15. Review.

39.

Biallelic Mutations in MRPS34 Lead to Instability of the Small Mitoribosomal Subunit and Leigh Syndrome.

Lake NJ, Webb BD, Stroud DA, Richman TR, Ruzzenente B, Compton AG, Mountford HS, Pulman J, Zangarelli C, Rio M, Boddaert N, Assouline Z, Sherpa MD, Schadt EE, Houten SM, Byrnes J, McCormick EM, Zolkipli-Cunningham Z, Haude K, Zhang Z, Retterer K, Bai R, Calvo SE, Mootha VK, Christodoulou J, Rötig A, Filipovska A, Cristian I, Falk MJ, Metodiev MD, Thorburn DR.

Am J Hum Genet. 2017 Aug 3;101(2):239-254. doi: 10.1016/j.ajhg.2017.07.005. Erratum in: Am J Hum Genet. 2018 Apr 5;102(4):713.

40.

Life-threatening airway bleeding after palliation of single ventricle congenital heart disease.

Averin K, Byrnes JW, Benscoter DT, Whiteside W, DeSena H, Hirsch R, Goldstein BH.

Heart. 2018 Feb;104(3):254-260. doi: 10.1136/heartjnl-2017-311764. Epub 2017 Aug 3.

PMID:
28775102
41.

Comparison of the EQ-5D-3L and the SF-6D (SF-12) contemporaneous utility scores in patients with cardiovascular disease.

Kularatna S, Byrnes J, Chan YK, Ski CF, Carrington M, Thompson D, Stewart S, Scuffham PA.

Qual Life Res. 2017 Dec;26(12):3399-3408. doi: 10.1007/s11136-017-1666-6. Epub 2017 Aug 1.

PMID:
28766084
42.

Pharmacologic modeling of primary mitochondrial respiratory chain dysfunction in zebrafish.

Byrnes J, Ganetzky R, Lightfoot R, Tzeng M, Nakamaru-Ogiso E, Seiler C, Falk MJ.

Neurochem Int. 2018 Jul;117:23-34. doi: 10.1016/j.neuint.2017.07.008. Epub 2017 Jul 18.

43.

Private Health Insurance Incentives in Australia: In Search of Cost-Effective Adjustments.

Sowa PM, Kault S, Byrnes J, Ng SK, Comans T, Scuffham PA.

Appl Health Econ Health Policy. 2018 Feb;16(1):31-41. doi: 10.1007/s40258-017-0338-6.

PMID:
28702875
44.

Utilizing a transfer of care bundle to reduce unplanned readmissions to the cardiac intensive care unit.

Storey J, Byrnes JW, Anderson J, Brown J, Clarke-Myers K, Kimball M, Meyer C, Mustin L, Schoenling G, Madsen N.

BMJ Qual Saf. 2018 Jan;27(1):66-72. doi: 10.1136/bmjqs-2016-006366. Epub 2017 Jul 8. No abstract available.

45.

Telephone consultations for general practice: a systematic review.

Downes MJ, Mervin MC, Byrnes JM, Scuffham PA.

Syst Rev. 2017 Jul 3;6(1):128. doi: 10.1186/s13643-017-0529-0. Review.

46.

Mapping Sri Lankan EQ-5D-3L to EQ-5D-5L Value Sets.

Kularatna S, Chen G, Byrnes J, Scuffham PA.

Value Health Reg Issues. 2017 May;12:20-23. doi: 10.1016/j.vhri.2017.01.001. Epub 2017 Apr 26.

PMID:
28648311
47.

Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty.

Golpanian S, DiFede DL, Khan A, Schulman IH, Landin AM, Tompkins BA, Heldman AW, Miki R, Goldstein BJ, Mushtaq M, Levis-Dusseau S, Byrnes JJ, Lowery M, Natsumeda M, Delgado C, Saltzman R, Vidro-Casiano M, Pujol MV, Da Fonseca M, Oliva AA Jr, Green G, Premer C, Medina A, Valasaki K, Florea V, Anderson E, El-Khorazaty J, Mendizabal A, Goldschmidt-Clermont PJ, Hare JM.

J Gerontol A Biol Sci Med Sci. 2017 Oct 12;72(11):1505-1512. doi: 10.1093/gerona/glx056.

48.

Public Preferences for the Use of Taxation and Labelling Policy Measures to Combat Obesity in Young Children in Australia.

Comans T, Moretto N, Byrnes J.

Int J Environ Res Public Health. 2017 Mar 21;14(3). pii: E324. doi: 10.3390/ijerph14030324.

49.

Cost-utility analysis for bariatric surgery compared with usual care for the treatment of obesity in Australia.

James R, Salton RI, Byrnes JM, Scuffham PA.

Surg Obes Relat Dis. 2017 Dec;13(12):2012-2020. doi: 10.1016/j.soard.2016.12.016. Epub 2016 Dec 26.

PMID:
28237564
50.

Fibrinogen and Fibrin in Hemostasis and Thrombosis.

Kattula S, Byrnes JR, Wolberg AS.

Arterioscler Thromb Vasc Biol. 2017 Mar;37(3):e13-e21. doi: 10.1161/ATVBAHA.117.308564. Review. No abstract available.

Supplemental Content

Loading ...
Support Center